Oncology Institute IncNASDAQ:TOI
- LAST PRICE1.2000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.4824/ 1
- Ask / Lots1.9100/ 10
- Open / Previous Close0.0000 / 1.2000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TOI |
|---|---|---|
| 09:32 ET | 750 | 1.195 |
| 10:03 ET | 200 | 1.195 |
| 10:06 ET | 431 | 1.1999 |
| 10:10 ET | 6576 | 1.16 |
| 10:17 ET | 100 | 1.17 |
| 10:26 ET | 361 | 1.2 |
| 10:44 ET | 100 | 1.2 |
| 10:48 ET | 241 | 1.2 |
| 10:53 ET | 100 | 1.19 |
| 11:13 ET | 100 | 1.17 |
| 11:38 ET | 1150 | 1.2201 |
| 11:56 ET | 196 | 1.2326 |
| 11:58 ET | 200 | 1.2308 |
| 12:00 ET | 100 | 1.23 |
| 01:15 ET | 1307 | 1.1901 |
| 01:30 ET | 100 | 1.2 |
| 01:32 ET | 100 | 1.2 |
| 02:51 ET | 100 | 1.2 |
| 03:43 ET | 17205 | 1.22 |
| 03:45 ET | 200 | 1.1906 |
| 03:48 ET | 100 | 1.19 |
| 03:50 ET | 200 | 1.19 |
| 03:52 ET | 500 | 1.19 |
| 03:56 ET | 200 | 1.23 |
| 03:57 ET | 500 | 1.2 |
| 03:59 ET | 3161 | 1.2 |
Apr 23, 2024
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call, from 8:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
8:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 8, 2024
Press Release: Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute, from 8:00AM ET on Monday Apr 08, 2024 by Dow Jones
8:00AM ET on Monday Apr 08, 2024 by Dow JonesJordan McInerney Appointed as Chief Development Officer of The Oncology Institute, from 8:00AM ET on Monday Apr 08, 2024 by Dow Jones
8:00AM ET on Monday Apr 08, 2024 by Dow Jones
Apr 4, 2024
Mar 27, 2024
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024, from 4:05PM ET on Wednesday Mar 27, 2024 by Dow Jones
4:05PM ET on Wednesday Mar 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oncology Institute Inc | 89.2M | -1.3x | --- |
Nutex Health Inc | 33.3M | -0.7x | --- |
DLH Holdings Corp | 155.0M | 83.2x | -29.78% |
American Well Corp | 154.4M | -0.2x | --- |
Prophase Labs Inc | 91.3M | -5.3x | --- |
Cryo-Cell International Inc | 63.8M | -6.7x | --- |
Company Information
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Contact Information
- Headquarters
- 18000 Studebaker Rd, Suite 800CERRITOS, CA, United States 90703
- Phone
- 562-735-3226
- Fax
- 302-636-5454
Executives
- Director
- Richard Barasch
- Chief Executive Officer
- Daniel Virnich
- Vice Chairman of the Board
- Brad Hively
- Chief Financial Officer
- Mihir Shah
- Chief Operating Officer
- Jeremy Castle
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $89.2M |
|---|---|
Revenue (TTM) | $324.2M |
Shares Outstanding | 74.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-0.92 |
Book Value | $0.77 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -23.75% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
